TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients

BACKGROUND: The Transforming growth factor β (TGFβ) signaling has a paradoxical role in cancer development and outcome. Besides, the prognostic significance of the TGFβ1, SMAD4 in breast cancer patients is an area of many contradictions. The transcriptional intermediary factor 1γ (TIF1γ) is thought...

詳細記述

保存先:
書誌詳細
出版年:BMC Cancer
主要な著者: Kassem, Loay, Deygas, Mathieu, Fattet, Laurent, Lopez, Jonathan, Goulvent, Thibaut, Lavergne, Emilie, Chabaud, Sylvie, Carrabin, Nicolas, Chopin, Nicolas, Bachelot, Thomas, Gillet, Germain, Treilleux, Isabelle, Rimokh, Ruth
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2015
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4453047/
https://ncbi.nlm.nih.gov/pubmed/26040677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1471-y
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料